Sanofi (SNYN) - Total Liabilities

Latest as of March 2026: MX$54.88 Billion MXN ≈ $3.16 Billion USD

Based on the latest financial reports, Sanofi (SNYN) has total liabilities worth MX$54.88 Billion MXN (≈ $3.16 Billion USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore SNYN year-over-year net asset growth to track the company's year-over-year net asset growth rate.

Sanofi - Total Liabilities Trend (2013–2025)

This chart illustrates how Sanofi's total liabilities have evolved over time, based on quarterly financial data. See Sanofi free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.

Sanofi Competitors by Total Liabilities

The table below lists competitors of Sanofi ranked by their total liabilities.

Company	Country	Total Liabilities
Delta Electronics (Thailand) Public Company Limited BK:DELTA	Thailand	฿48.70 Billion
Zijin Mining Group Co Ltd Class A SHG:601899	China	CN¥257.65 Billion
Quanta Services Inc NYSE:PWR	USA	$16.60 Billion
Pinduoduo Inc F:9PDA	Germany	€214.28 Billion
UBS Group AG SW:UBSG	Switzerland	CHF1.53 Trillion
GSK PLC SP. ADR/2 NEW F:GS70	Germany	€45.45 Billion
Brookfield Corporation TO:BN	Canada	CA$352.13 Billion
Air Liquide SA PA:AI	France	€24.97 Billion

Liability Composition Analysis (2013–2025)

This chart breaks down Sanofi's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see SNYN company net worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	1.01	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.75	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.43	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Sanofi's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Sanofi (2013–2025)

The table below shows the annual total liabilities of Sanofi from 2013 to 2025.

Year	Total Liabilities	Change
2025-12-31	MX$55.09 Billion ≈ $3.17 Billion	+0.28%
2024-12-31	MX$54.94 Billion ≈ $3.16 Billion	+5.43%
2023-12-31	MX$52.11 Billion ≈ $3.00 Billion	+2.03%
2022-12-31	MX$51.07 Billion ≈ $2.94 Billion	-0.27%
2021-12-31	MX$51.21 Billion ≈ $2.95 Billion	-0.33%
2020-12-31	MX$51.38 Billion ≈ $2.96 Billion	-4.19%
2019-12-31	MX$53.63 Billion ≈ $3.09 Billion	+2.40%
2018-12-31	MX$52.37 Billion ≈ $3.01 Billion	+25.99%
2017-12-31	MX$41.57 Billion ≈ $2.39 Billion	-11.46%
2016-12-31	MX$46.95 Billion ≈ $2.70 Billion	+6.43%
2015-12-31	MX$44.11 Billion ≈ $2.54 Billion	+7.26%
2014-12-31	MX$41.12 Billion ≈ $2.37 Billion	+5.39%
2013-12-31	MX$39.02 Billion ≈ $2.25 Billion	--

About Sanofi

MX:SNYN Mexico Drug Manufacturers - General

Market Cap

$102.08 Billion

MX$1.77 Trillion MXN

Market Cap Rank

#247 Global

#9 in Mexico

Share Price

MX$741.00

Change (1 day)

+0.00%

52-Week Range

MX$730.00 - MX$955.00

All Time High

MX$1212.00